CNR Institutional Research Information System

MORELLI, MICAELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 757
AS - Asia 227
EU - Europa 32
Totale 1.016
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 757
SG - Singapore 217
FI - Finlandia 17
IT - Italia 12
CN - Cina 7
AT - Austria 1
HK - Hong Kong 1
IE - Irlanda 1
JP - Giappone 1
KR - Corea 1
SE - Svezia 1
Totale 1.016
Salva come PNG Salva come JPEG
Città #
Santa Clara 727
Singapore 145
Helsinki 17
Rome 6
Cagliari 3
Ashburn 1
Dublin 1
Forest City 1
Hong Kong 1
Milan 1
Phoenix 1
Seoul 1
Tokyo 1
Vienna 1
Totale 907
Salva come PNG Salva come JPEG
Nome #
Withania somnifera influences MDMA-induced hyperthermic, cognitive, neurotoxic and neuroinflammatory effects in mice 19
In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J mice 19
null 14
Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms 12
null 12
Lack of rhes increases mdma-induced neuroinflammation and dopamine neuron degeneration: Role of gender and age 11
null 11
Control of Motor Function by Adenosine A2A Receptors in Parkinson's and Huntington's Disease 11
Neurofarmacologia nel trattamento della Malattia di Parkinson e nuovi approcci farmacologici 11
Fos expression induced by olanzapine and risperidone in the central extended amygdala 11
Farmaci Antiparkinsoniani ed Attivi in altri disturbi motori 11
Gender Differences in Neurodegeneration, Neuroinflammation and Na+-Ca2+ Exchangers in the Female A53T Transgenic Mouse Model of Parkinson's Disease 11
Modulatory role of adenosine A(2A) receptors in basal ganglia as basis for the use of A(2A) antagonists in the treatment of Parkinson's disease 10
ADENOSINE A2A ANTAGONISTS AND PARKINSON S DISEASE: NEW FINDINGS ON PARKINSONIAN TREMOR 10
C-FOS EXPRESSION AS A MOLECULAR MARKER IN CORTICOTROPIN-RELEASING FACTOR-INDUCED SEIZURES 10
Receptor Antagonism and Dyskinesia in Parkinson's Disease 10
RECEPTOR ANTAGONISTS IMPROVE AKINESIA AND SENSORY-MOTOR DEFICITS IN THE 6-HYDROXYDOPAMINE MODEL OF PARKINSON S DISEASE 10
Behavioural characterization of engrailed mutant mice as model of Parkinson's disease 10
PRIMING OF 6-HYDROXYDOPAMINE-LESIONED RATS WITH L-DOPA OR QUINPIROLE RESULTS IN AN INCREASE IN DOPAMINE D1 RECEPTOR-DEPENDENT CYCLIC AMP PRODUCTION IN STRIATAL TISSUE 10
ADENOSINE A2A RECEPTOR AGONISTS INCREASE FOS-LIKE IMMUNOREACTIVITY IN MESOLIMBIC AREAS 10
INDUCTION OF FOS-LIKE IMMUNOREACTIVITY IN THE CENTRAL EXTENDED AMYGDALA BY ANTIDEPRESSANT DRUGS 10
Neuroinflammation and activation of Zif-268 in dyskinetic 6-OHDA-lesioned rats is counteracted by association of a 5-HT1A/1B receptor agonist and an A(2A) receptor antagonist 10
Role of adenosine A(2A) receptors in motor control: relevance to Parkinson's disease and dyskinesia 10
Combined administration of dopaminergic and nondopaminergic drugs reverses neuroinflammation in a rat model of parkinson's disease 10
Subchronic intermittent caffeine administration to unilaterally 6-hydroxydopamine-lesioned rats sensitizes turning behaviour in response to dopamine D1 but not D2 receptor agonists 10
INTERACTION BETWEEN DOPAMINE AND ADENOSINE A2A RECEPTORS AS A BASIS FOR THE TREATMENT OF PARKINSON'S DISEASE 10
A novel therapeutic strategy for the prevention of the onset of dyskinesia in the therapy of Parkinson's disease 10
Influence of dopamine transmission in the medial prefrontal cortex and dorsal striatum on the emission of 50-kHz ultrasonic vocalizations in rats treated with amphetamine: Effects on drug-stimulated and conditioned calls 10
Involvement of the protein ras homolog enriched in the striatum, rhes, in dopaminergic neurons' degeneration: Link to parkinson's disease 10
Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists 10
Modulation of Rat 50-kHz Ultrasonic Vocalizations by Glucocorticoid Signaling: Possible Relevance to Reward and Motivation 10
Rhes counteracts dopamine neuron degeneration and neuroinflammation depending on gender and age 10
Repeated Administration of 3,4-Methylenedioxymethamphetamine (MDMA) Elevates the Levels of Neuronal Nitric Oxide Synthase in the Nigrostriatal System: Possible Relevance to Neurotoxicity 10
Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression 10
A novel therapeutic strategy to prevent the onset of dyskinesia in models of Parkinson's disease: acute and chronic studies. 10
MODULATION BY ADENOSINE A2A RECEPTORS OF DOPAMINE-MEDIATED MOTOR BEHAVIOR AS A BASIS FOR ANTIPARKINSON'S DISEASE DRUGS 10
Early α-synuclein/synapsin III co-accumulation, nigrostriatal dopaminergic synaptopathy and denervation in the MPTPp mouse model of Parkinson's Disease 10
ADENOSINE A2A RECEPTOR ANTAGONISTS IN THE THERAPY OF PARKINSON'S DISEASE 10
MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex 9
Decreased striatal adenosine extracellular levels and increased A2A receptors mRNA after dopamine denarvation 9
Symptomatic efficacy of mucuna pruriens seed extract in rodent model of Parkinson s disease 9
Adenosine A(2A) receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease. 9
The 6-hydroxydopamine model of Parkinson's disease 9
Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists 9
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 9
MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA pretreated mice 9
MDMA ADMINISTRATION DURING ADOLESCENCE EXACERBATES MPTP-INDUCED COGNITIVE IMPAIRMENT, NEURODEGENERATION AND NEUROINFLAMMATION IN MOTOR, LIMBIC AND CORTICAL AREAS 9
Stimulation of dopamine transmission in the dorsal caudate nucleus by pargyline as demonstrated by dopamine and acetylcholine microdialysis and Fos immunohistochemistry 9
Sanna E, Talani G, Obili N, Mascia MP, Mostallino MC, Secci PP, Pisu MG, Biggio F, Utzeri C, Olla P, Biggio G, Follesa P. Voluntary Ethanol Consumption Induced by Social Isolation Reverses the Increase of ±(4)/´ GABA(A) Receptor Gene Expression and Functi 9
ATTENUATION OF MPTP-INDUCED NEURODEGENERATION BY NCX 2216, A NITRIC OXIDE-RELEASING DERIVATIVE OF FLURBIPROFEN 9
Model of dyskinesia in 6-hydroxydopamine-lesioned rats: validity of sensitization in turning behaviour and abnormal involuntary movements. 9
New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists 9
Adenosine A2A receptor antagonists and Parkinson's disease: state of the art and future directions 9
Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats 9
Symptomatic and neuroprotective effects of A2A receptor antagonists in Parkinson's disease 9
Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons 9
Increase of dopamine D2(High) receptors in the striatum of rats sensitized to caffeine motor effects 9
Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent 9
Sensitisation in turning behaviour and abnormal involuntary movements in 6-hydroxydopamine lesioned rats: Influence of the environment in which tests are performed 9
Blockade of muscarinic receptors potentiates D1 dependent turning behavior and c-fos expression in 6-hydroxydopamine-lesioned rats but does not influence D2 mediated responses 9
Methylxanthines and drug dependence: a focus on interactions with substances of abuse 9
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease 9
Behavioral, Neurochemical, and Electrophysiological Changes in an Early Spontaneous Mouse Model of Nigrostriatal Degeneration 9
Adenosine A(2A) receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats 9
MOTOR STIMULANT EFFECTS OF THE ADENOSINE A2A RECEPTOR ANTAGONIST SCH 58261 DO NOT DEVELOP TOLERANCE AFTER REPEATED TREATMENTS IN 6-HYDROXYDOPAMINE-LESIONED RATS 9
Caffeine consumption and Changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine. Published in Advances in psychology research 9
BLOCKADE OF A2a ADENOSINE RECEPTORS POSITIVELY MODULATES TURNING BEHAVIOUR AND c-FOS EXPRESSION INDUCED BY D1 AGONISTS IN DOPAMINE-DENERVATED RATS 9
Therapeutic potential and antidyskinetic activity of the combined antagonism of adenosine A2A receptors and stimulation of 5HT1A/1B receptors in models of Parkinson's disease: acute and chronic studies. 9
INVOLVEMENT OF ADENOSINE A2A RECEPTORS IN THE INDUCTION OF C-FOS EXPRESSION BY CLOZAPINE AND HALOPERIDOL 9
M. Morelli, N. Simola, A. Pinna, S. Pontis 9
A2A receptor antagonists improve akinesia and sensory-motor deficits in the 6-hydroxydopamine model of Parkinson's disease 9
Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats. 9
MODULATORY ROLE OF ADENOSINE A2A RECEPTORS AS BASIS FOR THE USE OF A2A ANTAGONISTS IN THE TREATMENT OF PARKINSON S DISEASE 9
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioural and biochemical characterization as an antiparkinsonian drug 9
L-Dopa stimulates c-fos expression in dopamine denervated striatum by combined activation of D-1 and D-2 receptors 9
. Interaction between metabotropic adenosina A2A and glutamate MGLU5 receptors in parkinsonian-like muscle rigidity and tremor 8
SUBCHRONIC-INTERMITTENT CAFFEINE AMPLIFIES THE MOTOR EFFECTS OF AMPHETAMINE IN RATS 8
Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage 8
A Critical Evaluation of Behavioral Rodent Models of Motor Impairment Used for Screening of Antiparkinsonian Activity: The Case of Adenosine A(2A) Receptor Antagonists 8
'Priming' to dopamine agonist-induced contralateral turning as a model of non-associative sensitization to the expression of the post-synaptic dopamine message 8
ADENOSINE A2A RECEPTOR ANTAGONIST TREATMENT OF PARKINSON S DISEASE. In The basal ganglia pathophysiology: recent advances 8
Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease 8
Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats 8
Different patterns of behavior and gene expression induced by chronic L-dopa and A(2A) antagonists plus L-DOPA treatments in 6-hydroxydopamine lesioned rats 8
Behavioral and biochemical characterization as antiparkinsonian drug of the new adenosine A2A antagonist 8-ethoxy-9-ethyladenine 8
ALTERED RESPONSE OF STRIATAL AND PALLIDAL NEURONS AND UNBALANCED MODULATION OF SUBSTANTIA NIGRA RETICULATA ACTIVITY MAY UNDERLIE ABNORMAL MOVEMENTS IN SUBCHRONICALLY L-DOPA TREATED RATS. 8
SENSITIZATION TO TURNING BEHAVIOUR AND ABNORMAL INVOLUNTARY MOVEMENTS IN 6-HYDROXYDOPAMINE LESIONED RATS: INHFLUENCE OF THE ENVIRONMENT IN WHICH TESTS ARE PERFORMED 8
Combined microdialysis and Fos immunohistochemistry for the estimation of dopamine neurotransmission in the rat caudate-putamen 8
New adenosine A2A receptor antagonists: actions on Parkinson's disease models 8
Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: behavioural and biochemical evidence. 8
Neuroadaptive changes in striatum and substantia nigra reticulata associated with a dyskinetic L-DOPA treatment are not induced by the low dyskinetic drug ropinirole 8
ADENOSINE A(2) RECEPTORS STIMULATE C-FOS EXPRESSION IN STRIATAL NEURONS OF 6-HYDROXYDOPAMINE-LESIONED RATS 8
Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2- mediated behavior in the 6-hydroxydopamine model of turning: Relationship with c-fos expression 8
The Small GTP-Binding Protein Rhes Influences Nigrostriatal-Dependent Motor Behavior During Aging 8
Blockade of NMDA receptors differentially affects D-1 and D-2 mediated turning behavior in the 6-hydroxydopamine model of Parkinson 8
Priming of rotational behavior by a dopamine receptor agonist in Hemiparkinsonian rats: movement-dependent induction 8
FARMACI ANTIPARKINSONIANI ED ATTIVI IN ALTRI DISTURBI MOTORI, vol. 30 del Trattato di Farmacologia 8
Activation of adenosine A2A receptors suppresses the emission of pro-social and drug-stimulated 50-kHz ultrasonic vocalizations in rats: Possible relevance to reward and motivation 8
null 8
Differential effect of MK 801 and scopolamine on c-fos expression induced by L-dopa in the striatum of 6-hydroxydopamine lesioned rats 8
Totale 946
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.954
article - articoli 2.790
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 311
Totale 7.055
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20249 0 0 0 0 0 0 0 0 2 0 1 6
2024/20251.035 7 10 162 87 628 141 0 0 0 0 0 0
Totale 1.044